Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Measles Outbreak at a Privately Operated Detention Facility: Arizona, 2016.

Venkat H, Briggs G, Brady S, Komatsu K, Hill C, Leung J, Patel M, Livar E, Su CP, Kassem A, Sowers SB, Mercader S, Rota PA, Elson D, Timme E, Robinson S, Fitzpatrick K, Franco J, Hickman C, GastaƱaduy PA.

Clin Infect Dis. 2019 May 30;68(12):2018-2025. doi: 10.1093/cid/ciy819.

PMID:
30256908
2.

Development and Use of an Endpoint Titration Assay To Characterize Mumps IgG Avidity following Measles, Mumps, and Rubella Vaccination and Wild-Type Mumps Infection.

Mercader S, McGrew M, Sowers SB, Williams NJ, Bellini WJ, Hickman CJ.

mSphere. 2018 Sep 12;3(5). pii: e00320-18. doi: 10.1128/mSphere.00320-18.

3.

High Concentrations of Measles Neutralizing Antibodies and High-Avidity Measles IgG Accurately Identify Measles Reinfection Cases.

Sowers SB, Rota JS, Hickman CJ, Mercader S, Redd S, McNall RJ, Williams N, McGrew M, Walls ML, Rota PA, Bellini WJ.

Clin Vaccine Immunol. 2016 Aug 5;23(8):707-16. doi: 10.1128/CVI.00268-16. Print 2016 Aug.

4.

Immunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without Infection.

Siberry GK, Patel K, Bellini WJ, Karalius B, Purswani MU, Burchett SK, Meyer WA 3rd, Sowers SB, Ellis A, Van Dyke RB; Pediatric HIV AIDS Cohort Study (PHACS); Pediatric HIV AIDS Cohort Study PHACS.

Clin Infect Dis. 2015 Sep 15;61(6):988-95. doi: 10.1093/cid/civ440. Epub 2015 Jun 9.

5.

Outbreak of measles among persons with prior evidence of immunity, New York City, 2011.

Rosen JB, Rota JS, Hickman CJ, Sowers SB, Mercader S, Rota PA, Bellini WJ, Huang AJ, Doll MK, Zucker JR, Zimmerman CM.

Clin Infect Dis. 2014 May;58(9):1205-10. doi: 10.1093/cid/ciu105. Epub 2014 Feb 27.

PMID:
24585562
6.

Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method.

Latner DR, McGrew M, Williams NJ, Sowers SB, Bellini WJ, Hickman CJ.

Clin Vaccine Immunol. 2014 Mar;21(3):286-97. doi: 10.1128/CVI.00621-13. Epub 2013 Dec 26.

7.

Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy.

Abzug MJ, Qin M, Levin MJ, Fenton T, Beeler JA, Bellini WJ, Audet S, Sowers SB, Borkowsky W, Nachman SA, Pelton SI, Rosenblatt HM; International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 and P1061s Protocol Teams.

J Infect Dis. 2012 Aug 15;206(4):512-22. doi: 10.1093/infdis/jis386. Epub 2012 Jun 12.

8.

Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission.

Rota JS, Hickman CJ, Sowers SB, Rota PA, Mercader S, Bellini WJ.

J Infect Dis. 2011 Jul;204 Suppl 1:S559-63. doi: 10.1093/infdis/jir098.

PMID:
21666213
9.

Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals.

Hickman CJ, Hyde TB, Sowers SB, Mercader S, McGrew M, Williams NJ, Beeler JA, Audet S, Kiehl B, Nandy R, Tamin A, Bellini WJ.

J Infect Dis. 2011 Jul;204 Suppl 1:S549-58. doi: 10.1093/infdis/jir106.

PMID:
21666212
10.

Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006.

Rota JS, Turner JC, Yost-Daljev MK, Freeman M, Toney DM, Meisel E, Williams N, Sowers SB, Lowe L, Rota PA, Nicolai LA, Peake L, Bellini WJ.

J Med Virol. 2009 Oct;81(10):1819-25. doi: 10.1002/jmv.21557.

PMID:
19697404

Supplemental Content

Loading ...
Support Center